Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Adenis

Showing results (11-20 of 280) with videos related to

Pageof 28
Sort By:
Critical Reviews in Oncology/Hematology|June 7, 2011
Cyclophosphamide-based metronomic chemotherapy: after 10 years of experience, where do we stand and where are we going?Nicolas Penel, Antoine Adenis, Guido Bocci
Annals of Translational Medicine|January 5, 2018
Definitive chemoradiation for resectable carcinoma of the cervical esophagus: do we need more evidence?Antoine Adenis, Guillaume Piessen, David Azria
The Lancet. Oncology|November 17, 2012
Role of the investigator in phase 1 trials of anticancer drugsNicolas Penel, Antoine Adenis, Jacques Bonneterre
Plos Neglected Tropical Diseases|July 9, 2025
Large language models and their performance for the diagnosis of histoplasmosisMathieu Nacher, Ugo Françoise, Antoine Adenis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2019
Definitive Chemoradiotherapy for Esophageal Squamous Cell Cancer: A Matter of StandardAntoine Adenis, Gilles Crehange, Thierry Conroy
Current Opinion in Oncology|April 21, 2011
Metastatic pancreatic cancer: old drugs, new paradigmsThierry Conroy, Céline Gavoille, Antoine Adenis
Investigational New Drugs|May 9, 2009
Phase II trials in patients with carcinoma of unknown primary: a pooled data analysisAntoine Adenis, Charles Ferté, Nicolas Penel
Current Treatment Options in Oncology|December 11, 2007
Angiosarcomas and taxanesNicolas Penel, Amélie Lansiaux, Antoine Adenis
International Journal of Radiation Oncology, Biology, Physics|January 15, 2013
Is preoperative chemoradiation with paclitaxel and carboplatin a new standard of treatment for esophageal cancer?Antoine Adenis, Xavier Mirabel, Christophe Mariette
Oncology|September 5, 2009
Imatinib in gastrointestinal stromal tumor: does treatment duration matter?Antoine Adenis, Nicolas Penel, Jean-Yves Blay
Pageof 28

Showing results (11-20 of 280) with videos related to

Sort By:
Pageof 28
Critical Reviews in Oncology/Hematology|June 7, 2011
Cyclophosphamide-based metronomic chemotherapy: after 10 years of experience, where do we stand and where are we going?Nicolas Penel, Antoine Adenis, Guido Bocci
Annals of Translational Medicine|January 5, 2018
Definitive chemoradiation for resectable carcinoma of the cervical esophagus: do we need more evidence?Antoine Adenis, Guillaume Piessen, David Azria
The Lancet. Oncology|November 17, 2012
Role of the investigator in phase 1 trials of anticancer drugsNicolas Penel, Antoine Adenis, Jacques Bonneterre
Plos Neglected Tropical Diseases|July 9, 2025
Large language models and their performance for the diagnosis of histoplasmosisMathieu Nacher, Ugo Françoise, Antoine Adenis
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2019
Definitive Chemoradiotherapy for Esophageal Squamous Cell Cancer: A Matter of StandardAntoine Adenis, Gilles Crehange, Thierry Conroy
Current Opinion in Oncology|April 21, 2011
Metastatic pancreatic cancer: old drugs, new paradigmsThierry Conroy, Céline Gavoille, Antoine Adenis
Investigational New Drugs|May 9, 2009
Phase II trials in patients with carcinoma of unknown primary: a pooled data analysisAntoine Adenis, Charles Ferté, Nicolas Penel
Current Treatment Options in Oncology|December 11, 2007
Angiosarcomas and taxanesNicolas Penel, Amélie Lansiaux, Antoine Adenis
International Journal of Radiation Oncology, Biology, Physics|January 15, 2013
Is preoperative chemoradiation with paclitaxel and carboplatin a new standard of treatment for esophageal cancer?Antoine Adenis, Xavier Mirabel, Christophe Mariette
Oncology|September 5, 2009
Imatinib in gastrointestinal stromal tumor: does treatment duration matter?Antoine Adenis, Nicolas Penel, Jean-Yves Blay
Pageof 28